摘要 |
Use of compounds of the formula (I), in which X and X, identically or differently, are hydrogen, a C - to C -alkyl radical or a halogen atom or, if they are in adjacent positions, form a fused phenyl ring together with the carbon atoms carrying them, and R is an optionally substituted carbocyclic or heterocyclic saturated or unsaturated radical, and their physiologically tolerable salts, for the production of medicaments for diseases which are modulated via inhibition of phosphodiesterase(s) by cyclic nucleotides, in particular cyclic adenosine monophosphate. The diseases are more particularly proliferative disorders, including tumors, lymphomas, leukaemias, atherosclerosis and glomerulopathies, memory and/or learning ability disorders (inter alia Alzheimer's), impotence, erectile insufficiency and obesity, ischaemic or thrombolytic disorders, such as coronary infarct or cerebral infarct and additionally serum disorders. |
申请人 |
ROCHE DIAGNOSTICS GMBH;FRIEBE, WALTER-GUNAR;SCHAUMANN, WOLFGANG;WILHELMS, OTTO-HENNING |
发明人 |
FRIEBE, WALTER-GUNAR;SCHAUMANN, WOLFGANG;WILHELMS, OTTO-HENNING |